{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:49:50Z","timestamp":1788914990156,"version":"build-2803163510"},"reference-count":37,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,2,6]],"date-time":"2008-02-06T00:00:00Z","timestamp":1202256000000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Science"],"published-print":{"date-parts":[[2008,2]]},"abstract":"<jats:p>Metastatic prostate tumors in the bone microenvironment stimulate bone resorption, resulting in release of growth factors from the bone matrix that play important roles in tumor growth and osteoclast induction. Transforming growth factor \u03b2 (TGF\u03b2) is one of the most abundantly stored cytokines in bone matrix, regulating diverse biological activities. Here we evaluate its involvement in prostate tumor growth in the bone microenvironment, comparing with tumor growth in the subcutaneous microenvironment as a control. Rat prostate tumors were transplanted onto the cranial bone and into the subcutis of F344 male rats. Tumor cell proliferation, apoptosis, and TGF\u03b2 signal transduction were compared between the tumor\u2013bone interface and the tumor\u2013subcutaneous interface. Effects of TGF\u03b2 on osteoclast differentiation were also evaluated <jats:italic>in vitro<\/jats:italic>. Inhibitory effects of TGF\u03b2 receptor 1 antisense oligonucleotide on TGF\u03b2 signaling, osteolysis, osteoblasts, and tumor growth were examined <jats:italic>in vivo<\/jats:italic>. Osteolytic changes were extensively observed at the tumor\u2013bone interface, where the TGF\u03b2 level, TGF\u03b2 signal transduction, and tumor cell proliferation were higher than at the tumor\u2013subcutaneous interface. <jats:italic>In vitro<\/jats:italic> treatment with receptor activator of nuclear factor\u2010\u03baB ligand induced osteoclast differentiation of bone marrow stromal cells, and additional exposure to TGF\u03b2 exerted promotive effects on osteoclast induction. Intratumoral injection of TGF\u03b2 receptor 1 antisense oligonucleotide significantly reduced TGF\u03b2 signal transduction, osteolysis, induction of osteoclast and osteoblast, and tumor cell proliferation. Thus, we experimentally show that TGF\u03b2 derived from bone matrix promotes cell proliferation of rat prostate cancer and osteoclast activation\u2010associated osteolysis in the bone microenvironment. (<jats:italic>Cancer Sci<\/jats:italic> 2008; 99: 316\u2013323)<\/jats:p>","DOI":"10.1111\/j.1349-7006.2007.00690.x","type":"journal-article","created":{"date-parts":[[2008,2,6]],"date-time":"2008-02-06T08:10:47Z","timestamp":1202285447000},"page":"316-323","source":"Crossref","is-referenced-by-count":37,"title":["Transforming growth factor \u03b2 derived from bone matrix promotes cell proliferation of prostate cancer and osteoclast activation\u2010associated osteolysis in the bone microenvironment"],"prefix":"10.1111","volume":"99","author":[{"given":"Shinya","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Futakuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Asamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimihisa","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyofumi","family":"Asai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,2,6]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.57.1.43"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra030831"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041318"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040720"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8 <1546::AID-CNCR4>3.0.CO;2-I"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2006.050874"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc867"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevEukarGeneExpr.v10.i2.50"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11132"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650050708"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002640050290"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11140"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.2741\/1093"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.02-03-0037"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.111.2.731"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206420"},{"key":"e_1_2_7_18_2","volume-title":"Growth Factors and Cytokines in Health and Disease","author":"Delany AM","year":"1997"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M202561200"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI3523"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1293\/tox.11.27"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-005-0054-8"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.04.013"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/21.1.117"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-001-2034-6"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2005.09.021"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-1157"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-3601"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2006.00357.x"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-3565"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-2012"},{"key":"e_1_2_7_32_2","first-page":"1366","article-title":"Restoration of transforming growth factor \u03b2 signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase\u20101\u2010mediated apoptosis","volume":"59","author":"Guo Y","year":"1999","journal-title":"Cancer Res"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210272"},{"key":"e_1_2_7_34_2","first-page":"2931","article-title":"Soluble type II transforming growth factor\u2010\u03b2 (TGF\u2010\u03b2) receptor inhibits TGF\u2010\u03b2 signaling in COLO\u2010357 pancreatic cancer cells in vitro and attenuates tumor formation","volume":"7","author":"Rowland\u2010Goldsmith MA","year":"2001","journal-title":"Clin Cancer Res"},{"key":"e_1_2_7_35_2","first-page":"6021","article-title":"Inhibition of transforming growth factor\u2010\u03b2 activity decreases angiogenesis in a human prostate cancer\u2010reactive stroma xenograft model","volume":"62","author":"Tuxhorn JA","year":"2002","journal-title":"Cancer Res"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(99)00210-0"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600858"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.7.3679"}],"container-title":["Cancer Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.2007.00690.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.2007.00690.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T22:24:07Z","timestamp":1697235847000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.2007.00690.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["10.1111\/j.1349-7006.2007.00690.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.2007.00690.x","archive":["Portico"],"relation":{},"ISSN":["1347-9032","1349-7006"],"issn-type":[{"value":"1347-9032","type":"print"},{"value":"1349-7006","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}